Literature DB >> 17400502

Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA.

Niamh Roche1, Dag Ilver, Jonas Angström, Silvia Barone, John L Telford, Susann Teneberg.   

Abstract

Many bacterial toxins utilize cell surface glycoconjugate receptors for attachment to target cells. In the present study the potential carbohydrate binding of Helicobacter pylori vacuolating cytotoxin VacA was investigated by binding to human gastric glycosphingolipids on thin-layer chromatograms. Thereby a distinct binding of the toxin to two compounds in the non-acid glycosphingolipid fraction was detected. The VacA-binding glycosphingolipids were isolated and characterized by mass spectrometry and proton NMR as galactosylceramide (Galbeta1Cer) and galabiosylceramide (Galalpha4Galbeta1Cer). Comparison of the binding preferences of the protein to reference glycosphingolipids from other sources showed an additional recognition of glucosylceramide (Glcbeta1Cer), lactosylceramide (Galbeta4Glcbeta1Cer) and globotriaosylceramide (Galalpha4Galbeta4Glcbeta1Cer). No binding to the glycosphingolipids recognized by the VacA holotoxin was obtained with a mutant toxin with deletion of the 37 kDa fragment of VacA (P58 molecule). Collectively our data show that the VacA cytotoxin is a glycosphingolipid binding protein, where the 37 kDa moiety is required for carbohydrate recognition. The ability to bind to short chain glycosphingolipids will position the toxin close to the cell membrane, which may facilitate toxin internalization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400502     DOI: 10.1016/j.micinf.2007.01.023

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  12 in total

1.  Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells.

Authors:  Heather Parker; Kenny Chitcholtan; Mark B Hampton; Jacqueline I Keenan
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

2.  Helicobacter pylori-binding nonacid glycosphingolipids in the human stomach.

Authors:  Chunsheng Jin; Angela Barone; Thomas Borén; Susann Teneberg
Journal:  J Biol Chem       Date:  2018-09-19       Impact factor: 5.157

3.  Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain.

Authors:  Kelly A Gangwer; Darren J Mushrush; Devin L Stauff; Ben Spiller; Mark S McClain; Timothy L Cover; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

4.  Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells.

Authors:  Nadine Legros; Gottfried Pohlentz; Daniel Steil; Ivan U Kouzel; Ivan Liashkovich; Alexander Mellmann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2018-06-04       Impact factor: 5.922

5.  Helicobacter pylori vacuolating toxin A and apoptosis.

Authors:  Joachim Rassow
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

6.  the versatility of the Helicobacter pylori vacuolating cytotoxin vacA in signal transduction and molecular crosstalk.

Authors:  Steffen Backert; Nicole Tegtmeyer
Journal:  Toxins (Basel)       Date:  2010-01-15       Impact factor: 4.546

Review 7.  An Overview of Helicobacter pylori VacA Toxin Biology.

Authors:  Nora J Foegeding; Rhonda R Caston; Mark S McClain; Melanie D Ohi; Timothy L Cover
Journal:  Toxins (Basel)       Date:  2016-06-03       Impact factor: 4.546

8.  SHP2-Independent Tyrosine Dephosphorylation of Cortactin and Vinculin during Infection with Helicobacter pylori.

Authors:  Jakob Knorr; Steffen Backert; Nicole Tegtmeyer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2020-03-17

Review 9.  Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis.

Authors:  Samuel L Palframan; Terry Kwok; Kipros Gabriel
Journal:  Front Cell Infect Microbiol       Date:  2012-07-12       Impact factor: 5.293

10.  Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA.

Authors:  Vijay R Gupta; Hetal K Patel; Sean S Kostolansky; Roberto A Ballivian; Joseph Eichberg; Steven R Blanke
Journal:  PLoS Pathog       Date:  2008-05-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.